StockNews.com assumed coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a report issued on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Stock Performance Shares of NASDAQ VBLT opened at $0.16 on Monday. Vascular Biogenics has a fifty-two week low of $0.10 and a fifty-two week […]
StockNews.com began coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a report published on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Stock Down 8.8 % Shares of VBLT opened at $0.16 on Monday. The company has a market cap of $12.11 million, a PE ratio […]
StockNews.com began coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a research note issued to investors on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Price Performance NASDAQ VBLT opened at $0.16 on Friday. The business has a 50 day simple moving average of $0.20 and […]
Catalent (NYSE:CTLT – Get Free Report) and Vascular Biogenics (NASDAQ:VBLT – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, valuation, profitability and institutional ownership. Analyst Recommendations This is a breakdown of recent recommendations […]